BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 2, 2018
View Archived Issues
Pfizer enrolling patients in phase II study of PF-06823859 in moderate to severe dermatomyositis
Read More
PharmAbcine, MSD to evaluate TTAC-0001 with Keytruda
Read More
FDA awards rare pediatric disease designation to MeiraGTx's A-002
Read More
Starpharma receives approval to initiate phase I/II study of DEP cabazitaxel
Read More
Daiichi Sankyo reviews highlights of third quarter of fiscal 2017
Read More
Avelumab shows clinical activity in patients with previously treated mesothelioma
Read More
Phase II data on RX-3117 shows promise for pancreatic cancer treatment
Read More
UCB announces launch of Syndesi Therapeutics to develop therapeutics for cognitive disorders
Read More
Vical enters collaboration to advance candidate for invasive aspergillosis
Read More
FDA approves Avycaz for hospital-acquired and ventilator-associated bacterial pneumonias
Read More
Anika Therapeutics collaborates with University of Liverpool on MSC therapy for osteoarthritis
Read More
FDA grants priority review to patisiran NDA in hereditary ATTR amyloidosis
Read More
AVROBIO completes series B financing to advance gene therapy pipeline for lysosomal storage disorder
Read More
Sage Therapeutics presents new GABA(A) receptor modulators
Read More
CANbridge Life Sciences licenses rights to Nerlynx in Greater China
Read More
Medshine Discovery patents novel S1P1 agonists
Read More
Phase II/III Japanese study of safinamide meets primary endpoint
Read More
Aduro BioTech and Novartis patent STING-agonists
Read More
Crinetics Pharmaceuticals identifies new somatostatin SST2 receptor agonists
Read More
Syndax and AstraZeneca to test durvalumab plus SNDX-6352 in solid tumors
Read More
Roche presents new compounds for HBV
Read More
Japanese submission seeks approval of Ventana OptiView ALK as companion diagnostic for Alecensa
Read More
Affimed reveals new data from clinical studies of AFM-13
Read More
Veliparib combined with oxaliplatin and capecitabine proven safe in solid cancers
Read More
Five-year D-CARE trial of denosumab in breast cancer misses primary endpoint
Read More